Observational studyBMC neurology2025

Real-World Safety and Efficacy of 156 U - 195 U OnabotulinumtoxinA in Adults With Chronic Migraine: Results From the REPOSE Study.

Fayyaz Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.